Drug
Umbilical cord blood infusion
Umbilical cord blood infusion is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_2
2
40%
Ph not_applicable
1
20%
Ph phase_1
2
40%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Terminated(1)
Other(2)
Detailed Status
Completed2
unknown2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (40.0%)
Phase 22 (40.0%)
N/A1 (20.0%)
Trials by Status
completed240%
withdrawn120%
unknown240%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy
NCT01193660
unknownphase_1
Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients
NCT04013646
unknownphase_1
Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates
NCT02050971
withdrawnphase_2
FLT-PET Activity Change After Allogeneic Umbilical Cord Blood (UCB) Therapy in Cerebral Palsy
NCT01486732
completedphase_2
Umbilical Cord Blood Therapy for Cerebral Palsy
NCT01528436
Clinical Trials (5)
Showing 5 of 5 trials
NCT01193660Not Applicable
Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy
NCT04013646Phase 1
Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients
NCT02050971Phase 1
Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates
NCT01486732Phase 2
FLT-PET Activity Change After Allogeneic Umbilical Cord Blood (UCB) Therapy in Cerebral Palsy
NCT01528436Phase 2
Umbilical Cord Blood Therapy for Cerebral Palsy
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5